- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05412433
Clinic-based HIV Identification and Prevention Project Using Electronic Resources (CHIPPER)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Forty-two Obgyn providers will be randomized into 1 of three arms. Patients of enrolled providers who attend an ObGyn clinic for any preventative visit will complete an electronic history form (eHxForm) before clinic through a message sent through the patient portal (MyChart), email, or secure text messaging. The sexual history questions will be scored and categorized into 3 categories. Patients with a low score (0-3) will receive an electronic message offering a laboratory HIV test per USPSTF guidelines. If she accepts, then an automated Epic order will be placed for the provider to sign during the office visit.
Patients with a medium/high score (4-10) will be assigned a study arm based on their provider's group (arm 1: control, arm 2: patient will view score and a PrEP video, arm 3: procedures in arm 2 PLUS providers will receive an electronic health record alert that the patient may have HIV risk factors. This will occur automatically via programming integrated into the electronic health record. The primary outcome is PrEP uptake. The implementation strategy will be evaluated using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jenell Coleman, MD MPH
- Phone Number: 410-614-4496
- Email: colemanj@jhmi.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Recruiting
- Johns Hopkins Health System
-
Contact:
- Jenell Coleman, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients of enrolled providers aged 15-65 years
- Presenting for preventive care (i.e., well-woman exam, sexually transmitted infection testing, pre-conception counseling, or birth control).
Exclusion Criteria:
- Pregnant and has established prenatal care, i.e., visit is for prenatal care
- Non-English or non-Spanish speaking
- Living with HIV
- Unable to complete the eHxForm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard of Care
Participants in this arm will receive standard of care
|
Standard of care
|
Experimental: Patient Level + Multilevel
Participants in the arm will receive the patient level and multi-level intervention
|
Electronic data collection with scoring, patient awareness of HIV risk score, patient viewing of PrEP animations
Electronic data collection with scoring, patient awareness of HIV risk score, patient viewing of PrEP animations, provider electronic health records (EHR) alerts
|
Experimental: Multilevel
Participants in this arm will receive the multi-level intervention
|
Electronic data collection with scoring, patient awareness of HIV risk score, patient viewing of PrEP animations, provider electronic health records (EHR) alerts
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of PrEP prescriptions written for each patient
Time Frame: 4 weeks
|
Number of PrEP prescriptions written for each patient up to 4 weeks after office visit.
|
4 weeks
|
Adoption of Electronic History Form
Time Frame: 6 months
|
Proportion of consecutive eligible patients in each clinic who completed the eHxForm.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jenell Coleman, MD MPH, Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00331706
- 1R01MH132146 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PrEP
-
The University of Texas Health Science Center,...Merck Sharp & Dohme LLCCompletedPrEP Uptake Perspectives | PrEP Uptake Experiences | PrEP Adherence Perspectives | PrEP Adherence ExperiencesUnited States
-
University of ChicagoNorthwestern University; Ann & Robert H Lurie Children's Hospital of Chicago; Howard Brown Health Center and other collaboratorsRecruiting
-
Children's Mercy Hospital Kansas CityUniversity of North CarolinaWithdrawn
-
Brown UniversityCompletedAdherence, Medication | Stimulant Abuse | PrEP UptakeUnited States
-
Sebela Pharmaceuticals Development LLCCompletedColon Prep for ColonoscopyUnited States
-
Georgetown UniversityJohns Hopkins Bloomberg School of Public Health; United States Agency for International... and other collaboratorsRecruitingOral Pre-exposure Prophylaxis (PrEP) | Long-acting Injectable Cabotegravir for PrEPMalawi
-
Yale UniversityGilead SciencesNot yet recruitingHIV Prevention | PrEP Uptake | PrEP AwarenessUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health...Completed
-
Thai Red Cross AIDS Research CentreCompleted
-
University of Colorado, DenverNational Institute of Allergy and Infectious Diseases (NIAID); San Francisco...CompletedPrEP Adherence MonitoringUnited States
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted